NCCN Guidelines for Patients® | Bladder Cancer – For Patients | – For Clinicians NCCN Foundation ® gratefully acknowledges our industry supporter Pfizer, Inc. for its support in making available these NCCN Guidelines for Patients ® . NCCN independently develops and distributes the NCCN Guidelines for Patients. Our industry supporters do not participate in the development of the NCCN Guidelines for Patients and are not responsible for the content and recommendations contained therein. PAT-N-1149-0619 Bladder Cancer Urothelial Carcinoma 3025 Chemical Road, Suite 100 Plymouth Meeting, PA 19462 215.690.0300 NCCN GUIDELINES FOR PATIENTS ® 2019